IDTA Identa Corp (QB)

IDenta Corp. (PINKSHEETS: IDTA) CEO Yaacov Shoham today announced that IDenta Corp. has signed an agreement with a large drug store chain to sell the General Screening Drug Testing Kits and Marijuana Kits in all of the chains thousands of stores."

The kits are expected to be on the shelves at the beginning of September 2012.

The 25,000 kits in the first order are one of the largest orders received by IDenta Corp. from one customer.

IDenta's ready-to-use drug testing kits will allow the purchaser to accurately and instant identify suspected illegal substances such as: tablets, pills, liquids, powder, residue, etc.

These home drug testing kits are directed specifically for the retail consumer market: worried parents, schools and work place. The kits allow you to identify substances in the comfort of your own home, quickly and discreetly.

Mr. Shoham stated, "This event is one of the most important steps since IDenta Corp. was established. IDenta's sales projections for the drug store chain show a very large number of kits being sold annually.

"Making these kits available to the public will fill a need that up until now has not been met.

"The IDenta Corp.'s drug detector kits are the only kits on the market to be able to be sold on the retail market.

"We at IDenta Corp. are confident that this step will change the status of the company on the stock market also. A first step was already done by upgrading the company's tier to limited information."

IDenta's entire product line may be found at www.Identa-corp.com, www.drugsdetector.com and www.Identa.biz

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.drugsdetector.com, www.identa.biz, www.identa-corp.com

Contact: Yaacov Shoham IDenta Corp. CEO Tel: +972-52-6554487 fpi@drugsdetector.com http://www.identa.biz